Doctor On Demand’s telemedicine healthcare app

By William Smith
Doctor On Demand is a San Francisco, California-based startup providing, as the name suggests, on-demand access to virtual care...

Doctor On Demand is a San Francisco, California-based startup providing, as the name suggests, on-demand access to virtual care.

The ongoing COVID-19 pandemic has only increased the necessity of telemedicine and virtual care. It is precisely this which Doctor On Demand offers, with 24/7 access to US-based medical professionals, accessible nationwide with or without insurance. In the sixth months, spurred on by the pandemic, the service recorded is three millionth virtual visit.

The company was founded in 2012, and has since raised around $235mn across six funding rounds. Its latest Series D round, announced earlier this month, raised the company some $75mn in a round led by General Atlantic, with support from existing investors.

In a press release, Hill Ferguson, CEO of Doctor On Demand, said: “COVID-19 awakened the industry to the benefits of virtual care as a means to reach all patient populations, and at the same time, demonstrated the high quality of care that can be delivered in a virtual-first setting. Doctor On Demand will remain dedicated to delivering high-quality, compassionate care to our patients, and innovative, cost-effective solutions to our partners as we continue to expand access and launch new capabilities.”

The company said it would use the funds to accelerate its growth and expand access to its products across the US.

“Doctor On Demand is a virtual care pioneer in both video-based consults and virtual primary care, with a differentiated clinical model and behavioral health offering that allows the company to efficiently scale and provide value to patients, providers, and payers alike,” said Robbert Vorhoff, Managing Director and Global Head of Healthcare at General Atlantic. “We believe virtual care has reached an inflection point, with significantly increased adoption levels, and that Doctor On Demand is well positioned to capture the sustained growth of the broader industry.”

Share

Featured Articles

Comarch Diagnostic Point Boost for European Health Insurance

Healthtech specialist Comarch introduces Diagnostic Point, designed to improve health insurance across European markets

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Procurement & Supply Chain

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma